[Treatment of male breast cancer: an analysis of 41 cases].

41 male patients with breast cancer confirmed pathologically were treated. Of these, 35 were treated by radical mastectomy and 6 by modified radical mastectomy. The patients with axillary lymphatic metastasis were treated by postoperative radiotherapy, chemotherapy. The overall 5-, 10- and 15-year survival rates were 67.6%, 53.3% and 55.0%, respectively. The 15 year survival rates of TNM stage I-II and III patients were 55% and 50% respectively. We conclude that radical or modified radical mastectomy is the rational therapy for male breast cancer. The patients in stage III will benefit from postoperative adjuvant therapy in terms of improving prognosis.
AuthorsM T Yang
JournalZhonghua wai ke za zhi [Chinese journal of surgery] (Zhonghua Wai Ke Za Zhi) Vol. 31 Issue 5 Pg. 290-2 (May 1993) ISSN: 0529-5815 [Print] CHINA
PMID8112159 (Publication Type: English Abstract, Journal Article)
  • Adenocarcinoma (surgery)
  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms (mortality, surgery)
  • Carcinoma, Intraductal, Noninfiltrating (surgery)
  • Humans
  • Male
  • Mastectomy, Modified Radical
  • Mastectomy, Radical
  • Middle Aged
  • Sex Factors
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: